X T L Biopharmaceuticals Ltd (XTLB) Stock Price & News

XTLB:NASDAQ

X T L Biopharmaceuticals Ltd

$2.52

0.00%

(0.00) 1D

Sep 9, 2:55:03 PM GMT-4 · USD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for XTLB...

Mkt. cap

10.69M

Avg. vol.

9.42K

Volume

4.00

52-wk high

$10.28

52-wk low

$2.02

EPS

-$0.34

Beta

1.01

Shares outstanding

4.24M

No. of employees

Mkt. cap

10.69M

Avg. vol.

9.42K

Volume

4.00

52-wk high

$10.28

52-wk low

$2.02

EPS

-$0.34

Beta

1.01

Shares outstanding

4.24M

No. of employees

Related stocks

Purple Biotech Ltd - ADR

Foresight Autonomous Holdings ADR

$1.11

+0.91%

News stories

From web sources and news partners

https://www.dars.gov.et/

3 months ago

XTL Biopharmaceuticals (XTLB) Drops Over 7%: Testing Crucial Support at $1.97 - Fear Greed Extreme

About X T L Biopharmaceuticals Ltd

CEO-

Employees5

Founded1993

HeadquartersHerzliya, Tel Aviv District, Israel

SectorBiotechnology

Websitextlbio.com

All values in USD	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	258.50K	258.50K	-	-
Cost of goods sold	1.39M	1.39M	-	-
Cost of revenue	1.39M	1.39M	-	-
Research and development expenses	10.50K	10.50K	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	956.00K	956.00K	-	-
Operating expense	1.08M	1.08M	-	-
Total operating expenses	2.46M	2.46M	-	-
Operating income	-2.21M	-2.21M	-	-
Other non operating income	500.00	500.00	-	-
EBT including unusual items	-2.86M	-2.86M	-	-
EBT excluding unusual items	-2.23M	-2.23M	-	-
Income tax expense	-109.50K	-109.50K	-	-
Effective tax rate	3.83%	3.83%	-	-
Other operating expenses	111.50K	111.50K	-	-
Net income	-2.75M	-2.75M	-	-
Net profit margin	-1,063.83%	-1,063.83%	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-25.50K	-25.50K	-	-
Net interest expenses	-25.50K	-25.50K	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-2.16M	-2.16M	-	-
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything